Skip to main content
. 2014 Aug 21;30(5):285–294. doi: 10.3109/02656736.2014.936049

Figure 1.

Figure 1.

Pharmacokinetic profiles for cycles 1 and 2 at each dose level for doxorubicin and its cardiotoxic metabolite, doxorubicinol. The half-life of the drug was the same for cycle 1 and cycle 2 and was not dependent upon doxorubicin dose.